{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:33:31Z","timestamp":1772120011729,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s12149-023-01855-8","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T05:02:06Z","timestamp":1688706126000},"page":"535-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic values of delayed additional FDG PET\/CT scan in the evaluation of cardiac sarcoidosis"],"prefix":"10.1007","volume":"37","author":[{"given":"Osamu","family":"Manabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisataka","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Ibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0394-0095","authenticated-orcid":false,"given":"Noriko","family":"Oyama-Manabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"1855_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68:411\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"1855_CR2","doi-asserted-by":"publisher","first-page":"00516","DOI":"10.1183\/23120541.00516-2021","volume":"8","author":"H Ohira","year":"2022","unstructured":"Ohira H, Sato T, Manabe O, Oyama-Manabe N, Hayashishita A, Nakaya T, et al. Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis. ERJ Open Res. 2022;8:00516\u20132021.","journal-title":"ERJ Open Res"},{"key":"1855_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12149-020-01519-x","volume":"34","author":"O Manabe","year":"2020","unstructured":"Manabe O, Naya M, Aikawa T, Tamaki N. Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging. Ann Nucl Med. 2020;34:697\u2013706.","journal-title":"Ann Nucl Med"},{"key":"1855_CR4","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s12350-019-01755-3","volume":"26","author":"S Kumita","year":"2019","unstructured":"Kumita S, Yoshinaga K, Miyagawa M, Momose M, Kiso K, Kasai T, et al. Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations. J Nucl Cardiol. 2019;26:1414\u201333.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12149-014-0806-0","volume":"28","author":"Y Ishida","year":"2014","unstructured":"Ishida Y, Yoshinaga K, Miyagawa M, Moroi M, Kondoh C, Kiso K, et al. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations. Ann Nucl Med. 2014;28:393\u2013403.","journal-title":"Ann Nucl Med"},{"key":"1855_CR6","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2214\/AJR.19.22571","volume":"215","author":"C \u00d6z\u00fctemiz","year":"2020","unstructured":"\u00d6z\u00fctemiz C, Neil EC, Tanwar M, Rubin NT, Ozturk K, Cayci Z. The Role of Dual-Phase FDG PET\/CT in the Diagnosis and Follow-Up of Brain Tumors. AJR Am J Roentgenol. 2020;215:985\u201396.","journal-title":"AJR Am J Roentgenol"},{"key":"1855_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12149-012-0599-y","volume":"26","author":"KK Miyake","year":"2012","unstructured":"Miyake KK, Nakamoto Y, Togashi K. Dual-time-point 18F-FDG PET\/CT in patients with colorectal cancer: clinical value of early delayed scanning. Ann Nucl Med. 2012;26:492\u2013500.","journal-title":"Ann Nucl Med"},{"key":"1855_CR8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12149-012-0619-y","volume":"26","author":"T Shinya","year":"2012","unstructured":"Shinya T, Fujii S, Asakura S, Taniguchi T, Yoshio K, Alafate A, et al. Dual-time-point F-18 FDG PET\/CT for evaluation in patients with malignant lymphoma. Ann Nucl Med. 2012;26:616\u201321.","journal-title":"Ann Nucl Med"},{"key":"1855_CR9","doi-asserted-by":"publisher","first-page":"15180","DOI":"10.1038\/s41598-019-51800-x","volume":"9","author":"JS Rosenblum","year":"2019","unstructured":"Rosenblum JS, Quinn KA, Rimland CA, Mehta NN, Ahlman MA, Grayson PC. Clinical Factors Associated with Time-Specific Distribution of 18F-Fluorodeoxyglucose in Large-Vessel Vasculitis. Sci Rep. 2019;9:15180.","journal-title":"Sci Rep"},{"key":"1855_CR10","first-page":"222","volume":"32","author":"I Mart\u00ednez-Rodr\u00edguez","year":"2013","unstructured":"Mart\u00ednez-Rodr\u00edguez I, del Castillo-Matos R, Quirce R, Jim\u00e9nez-Bonilla J, de Arcocha-Torres M, Ortega-Nava F, et al. Comparison of early (60 min) and delayed (180 min) acquisition of 18F-FDG PET\/CT in large vessel vasculitis. Rev Esp Med Nucl Imagen Mol. 2013;32:222\u20136.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1855_CR11","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s12350-021-02815-3","volume":"30","author":"S Kato","year":"2023","unstructured":"Kato S, Aikawa T, Ibe T, Manabe O, Oyama-Manabe N. Delayed 18F-fluorodeoxyglucose PET\/CT imaging improves detection of cardiac involvement in sarcoidosis. J Nucl Cardiol. 2023;30:417\u20139.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-022-03151-w","author":"T Aikawa","year":"2022","unstructured":"Aikawa T, Manabe O, Ibe T, Oyama-Manabe N. Serial assessment of cardiac involvement in sarcoidosis by delayed. J Nucl Cardiol. 2022. https:\/\/doi.org\/10.1007\/s12350-022-03151-w.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR13","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","volume":"83","author":"F Terasaki","year":"2019","unstructured":"Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J. 2019;83:2329\u201388.","journal-title":"Circ J"},{"key":"1855_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12350-015-0226-0","volume":"23","author":"O Manabe","year":"2016","unstructured":"Manabe O, Yoshinaga K, Ohira H, Masuda A, Sato T, Tsujino I, et al. The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial (18)F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis. J Nucl Cardiol. 2016;23:244\u201352.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105682","volume":"9","author":"K Hirata","year":"2014","unstructured":"Hirata K, Kobayashi K, Wong KP, Manabe O, Surmak A, Tamaki N, et al. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS ONE. 2014;9: e105682.","journal-title":"PLoS ONE"},{"key":"1855_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11:1305\u201323.","journal-title":"Heart Rhythm"},{"key":"1855_CR17","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1148\/radiol.213170","volume":"304","author":"M Aitken","year":"2022","unstructured":"Aitken M, Chan MV, Urzua Fresno C, Farrell A, Islam N, McInnes MDF, et al. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology. 2022;304:566\u201379.","journal-title":"Radiology"},{"key":"1855_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","volume":"21","author":"MT Osborne","year":"2014","unstructured":"Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21:166\u201374.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","volume":"21","author":"A Ahmadian","year":"2014","unstructured":"Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M, et al. Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21:925\u201339.","journal-title":"J Nucl Cardiol"},{"key":"1855_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ijcard.2015.05.075","volume":"195","author":"R Yokoyama","year":"2015","unstructured":"Yokoyama R, Miyagawa M, Okayama H, Inoue T, Miki H, Ogimoto A, et al. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET\/CT for detection of cardiac sarcoidosis. Int J Cardiol. 2015;195:180\u20137.","journal-title":"Int J Cardiol"},{"key":"1855_CR21","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00259-023-06168-6","volume":"50","author":"D Adili","year":"2023","unstructured":"Adili D, Cai D, Wu B, Yu H, Gu Y, Zhang Y, et al. An exploration of the feasibility and clinical value of half-dose 5-h total-body. Eur J Nucl Med Mol Imaging. 2023;50:2375\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-023-01855-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-023-01855-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T23:40:52Z","timestamp":1695166852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-023-01855-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1855"],"URL":"https:\/\/doi.org\/10.1007\/s12149-023-01855-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2949688\/v1","asserted-by":"object"}]},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]},"assertion":[{"value":"17 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Noriko Oyama-Manabe received payments from Bayer Yakuhin Ltd. and Canon Medical Systems for lectures. The other authors declare no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional ethics review board approval was obtained, and the requirement for informed consent was waived for this retrospective study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}